Dr. Deepak L. Bhatt (@DLBHATTMD) header
Dr. Deepak L. Bhatt (@DLBHATTMD) profile picture

Dr. Deepak L. Bhatt is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine. Bio and COI: https://teapawt.net/t.co/ngtk4hxfDG.

New York City
Joined December 2009
Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)Photo by Dr. Deepak L. Bhatt (@DLBHATTMD)
After 14 wonderful years at @BrighamWomens, @MassGenBrigham, @DanaFarber, and @VABostonHC, I am happy to announce that I will be the Director of @MountSinaiHeart at @MountSinaiNYC and the Dr. Valentin Fuster Professor of CV Medicine at @IcahnMountSinai. mountsinai.org/about/newsroo…
274
92
21
1,509
See our recap of the hottest trials at #AHA26 during the @ACCinTouch Cardiology Hour! #cardiology #cardiovascular #cardiotwitter #cardioX @AHAScience @AHAMeetings
Mount Sinai was proud to support the ACC Cardiology Hour at #ScientificSessions26. Led by Valentin Fuster, MD, PhD, MACC, and joined by @DLBHATTMD, a panel of experts engaged in an insightful discussion of some of the meeting’s key late-breaking trials. The panel went beyond the trial results to consider their implications for clinical practice and future research. Watch the episode here: mshs.co/48WhPsy @MountSinaiHeart @ACCinTouch @JACCJournals @AHAScience @American_Heart #CardioX #Cardiology #Research
17
1,334
Dr. Deepak L. Bhatt retweeted
🤝@GoHealio caught up with @DLBHATTMD of @MountSinaiHeart at @ScientificSessions26 to discuss the late-breaking science from @American_Heart's meeting. Stay tuned for his expert perspective on HORIZON-Lp(a) and more!❤️
3
30
1,715
Dr. Deepak L. Bhatt retweeted
🎥 New ACC Cardiology Hour! Valentin Fuster, MD, PhD, MACC, and a panel of experts discuss the key late-breaking trials from #ScientificSessions26, including ZEUS, Lp(a)HORIZON, HORIZON Outcomes & more. Watch the video ➡️ bit.ly/3Umnncw @DLBHATTMD #CardioX
5
38
2,428
Dr. Deepak L. Bhatt retweeted
Congratulations to @NancyatHeart and the planning committee on a spectacular @American_Heart meeting in Chicago - as well as bringing the festive Diwali spirit to the AHA reception! #AHA26 #cardiology #cardioX @manesh_patelMD @HeartBobH @AHANewYorkCity
6
82
3,774
🎥 New ACC Cardiology Hour! Valentin Fuster, MD, PhD, MACC, and a panel of experts discuss the key late-breaking trials from #ScientificSessions26, including ZEUS, Lp(a)HORIZON, HORIZON Outcomes & more. Watch the video ➡️ bit.ly/3Umnncw @DLBHATTMD #CardioX
5
38
2,428
Congratulations to @NancyatHeart and the planning committee on a spectacular @American_Heart meeting in Chicago - as well as bringing the festive Diwali spirit to the AHA reception! #AHA26 #cardiology #cardioX @manesh_patelMD @HeartBobH @AHANewYorkCity
6
82
3,774
🤝@GoHealio caught up with @DLBHATTMD of @MountSinaiHeart at @ScientificSessions26 to discuss the late-breaking science from @American_Heart's meeting. Stay tuned for his expert perspective on HORIZON-Lp(a) and more!❤️
3
30
1,715
See our debate on whether to measure Lp(a). #AHA26 #cardiology #CardioX #CardioTwitter #prevention
How should lp(a) be used to guide #CV_prevention in the absence of benefit of lp(a)-lowering ? Read our debate paper in @ESC_Journals #EJPC @DLBHATTMD @AboyansV @EAPCPresident @vass_vassiliou @gbiondizoccai
17
1,380
Dr. Deepak L. Bhatt retweeted
From breakthrough research in acute coronary syndromes to innovations in coronary artery disease and cardiovascular-kidney-metabolic health, hear from @DLBHATTMD at #ScientificSessions26. @AHAScience @IcahnMountSinai #CardioX #Cardiology
2
25
1,872
See our debate on whether to measure Lp(a). #AHA26 #cardiology #CardioX #CardioTwitter
✅Lp(a) at the #AHA26 - no 💊 pharma yet on the HORIZON. So should we still screen it ? Does Knowing Lp(a) Change What We Do? See the debate in #EJPC ⤵️ academic.oup.com/eurjpc/arti… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic @GalTsaban @DLBHATTMD
3
5
37
5,932
See our debate on whether to measure Lp(a). #AHA26 #cardiology #CardioX #CardioTwitter
This quoted post is unavailable.
1
11
920
Kicking off #AHA2026 with these amazing colleagues. Awaiting full results of HORIZON and ZEUS.@BudoffMd @DLBHATTMD Leslie Cho.
2
33
1,543
What we know from Lp(a)HORIZON and what remains unknown The Lp(a)HORIZON trial is a landmark study whose negative primary endpoint result must be interpreted with the precision the underlying science demands. The causal role of Lp(a), the ability to lower Lp(a) pharmacologically, and the clinical benefit of that reduction are distinct propositions, and only the third is directly tested by this trial. @DLBHATTMD @DrMarthaGulati @hvanspall @CMichaelGibson sciencedirect.com/science/ar…
3
1
12
1,590
Dr. Deepak L. Bhatt retweeted
Some thoughts about HORIZON as we await the formal data at #AHA26. #cardiology #cardiovascular #prevention #cardiotwitter #cardioX
Lp(a)HORIZON was negative. But what exactly did it disprove? Not that Lp(a) is causal. Not that we can lower it. It challenged whether pharmacologic lowering reduces events. The full data with component outcomes, precision, subgroup analyses, and timing will determine what comes next. New viewpoint in @PCVDJournal @AbdelazizMD1 @DLBHATTMD @ElsevierConnect sciencedirect.com/science/ar…
3
6
1
30
2,768
From breakthrough research in acute coronary syndromes to innovations in coronary artery disease and cardiovascular-kidney-metabolic health, hear from @DLBHATTMD at #ScientificSessions26. @AHAScience @IcahnMountSinai #CardioX #Cardiology
2
25
1,872
Some thoughts about HORIZON as we await the formal data at #AHA26. #cardiology #cardiovascular #prevention #cardiotwitter #cardioX
Lp(a)HORIZON was negative. But what exactly did it disprove? Not that Lp(a) is causal. Not that we can lower it. It challenged whether pharmacologic lowering reduces events. The full data with component outcomes, precision, subgroup analyses, and timing will determine what comes next. New viewpoint in @PCVDJournal @AbdelazizMD1 @DLBHATTMD @ElsevierConnect sciencedirect.com/science/ar…
3
6
1
30
2,768